ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BMK Benchmark Holdings Plc

43.25
0.00 (0.00%)
18 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Benchmark Holdings Plc LSE:BMK London Ordinary Share GB00BGHPT808 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 43.25 43.00 43.50 43.50 43.50 43.50 40 16:35:25
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 169.74M -23.15M -0.0313 -13.90 321.62M
Benchmark Holdings Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker BMK. The last closing price for Benchmark was 43.25p. Over the last year, Benchmark shares have traded in a share price range of 33.80p to 48.00p.

Benchmark currently has 739,352,390 shares in issue. The market capitalisation of Benchmark is £321.62 million. Benchmark has a price to earnings ratio (PE ratio) of -13.90.

Benchmark Share Discussion Threads

Showing 226 to 245 of 1100 messages
Chat Pages: Latest  20  19  18  17  16  15  14  13  12  11  10  9  Older
DateSubjectAuthorDiscuss
27/1/2015
08:41
Ha glad I qualified it...
hydrus
27/1/2015
08:26
Hmm not convinced it will fall that far but who knows.
hydrus
27/1/2015
08:22
Looking to buy some back if it gets back to the placing price. Think price got a bit carried away after it was tipped.
phowdo
27/1/2015
08:16
Seems like an overreaction, massive growth prospects here
hydrus
19/1/2015
15:24
If you would like to hear Benchmark discuss their full year results we will be hosting a webinar with company management on the 28th of January at 2.30pm.

They will give a 25 minute presentation with an opportunity for Q&A at the end.

If you would like to participate, please register now:



After registering, you will receive a confirmation email containing information about joining the webinar.

If you would like to submit any questions for management ahead of the meeting please send them to hannah@equitydevelopment.co.uk.

Thanks,
The Equity Development Team

hannahh
09/1/2015
09:11
Next stop 140.
cestnous
08/1/2015
16:52
Thanks Cest. Upped my stake by 50% (200)
petewy
08/1/2015
14:31
Woodford goes from 10 to 14.5% :¬)
cestnous
07/1/2015
10:03
145 first stop cestnous
gucci
06/1/2015
13:31
Invesco gone from 15.5 mil. to 29 mil.
cestnous
29/12/2014
20:17
JakNife,

The directors have not sold any shares at all during this fundraising. However, the process of issuing additional shares which have been bought by institutions enlarged the total number of shares in issue. Whilst the number of shares owned by directors remained static the percentage of the company they owned reduced, therefore their holding is said to be diluted. Price is irrelevant.

Dibbs

dibbs
29/12/2014
16:37
Haven't they only been diluted by recent placement?
phowdo
12/12/2014
12:12
Hi,

Our new note on Benchmark is available on our website: www.equitydevelopment.co.uk

Registration is free.

Thanks,
The Equity Development team

hannahh
11/12/2014
12:48
Equity Development note out:
VALUATION
"Extending our previous analysis (see notes, 10 September and 24 June) we
believe that a discounted cash flow (DCF) analysis give a relatively clear view on
potential cash flows from market expansion and product campaigns, fuelled by
BMK's growing product development portfolio.
Our DCF matrix, using a 10%-12% discount rate assumption and long-term FCF
growth of 1.5%-3.0%, comfortably justifies the current market value. Depending
on future positive news regarding product development (including HypoCat - not
in current valuation) and other catalysts, we anticipate further value creation.
Choosing an average from 10.0% - 14.0%, and adjusting for FY14e's net debt,
suggests a market capitalisation of ~£312m.

In terms of the new number of shares, this would equate to fair value per share of 142 pence."

aishah
10/12/2014
16:00
Cheers Gucci; may we both make a mint :¬)
cestnous
09/12/2014
14:08
nice lot of buying and l2 looking strong
gucci
09/12/2014
12:25
wellcome Cestnous
gucci
09/12/2014
11:33
Hi all, Just bought in.
cestnous
09/12/2014
09:31
good chance for a topup at these levels - on support
gucci
08/12/2014
14:00
this tends to shoot up quite fast
hoping for the last highs again soon

gucci
Chat Pages: Latest  20  19  18  17  16  15  14  13  12  11  10  9  Older

Your Recent History

Delayed Upgrade Clock